An investigation of the auto-induction of and gender-related variability in the pharmacokinetics of dihydroartemisinin in the rat
详细信息 查看全文
- 作者：Fanping Zhu (1)
Fuying Du (1)
Xinxiu Li (1)
Jie Xing (1) - 关键词：Dihydroartemisinin ; Metabolites ; Autoinduction ; Sex difference
- 刊名：Malaria Journal
- 出版年：2012
- 出版时间：December 2012
- 年：2012
- 卷：11
- 期：1
- 全文大小：373KB
- 参考文献：1. Myint HY, Ashley EA, Day NP, Nosten F, White NJ: Efficacy and safety of dihydroartemisinin-piperaquine. / Trans R Soc Trop Med Hyg 2007, 101:858-66. CrossRef
2. Keating GM: Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria. / Drugs 2012, 72:937-61. CrossRef
3. Hamed K, Grueninger H: Coartem( ? ): a decade of patient-centric malaria management. / Expert Rev Anti Infect Ther 2012, 10:645-59. CrossRef
4. Jamsen KM, Duffull SB, Tarning J, Lindegardh N, White NJ, Simpson JA: Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria. / Malar J 2011, 10:181. CrossRef
5. Ilett KF, Ethell BT, Maggs JL, Davis TM, Batty KT, Burchell B, Binh TQ, le Thu TA, Hung NC, Pirmohamed M, Park BK, Edwards G: Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases. / Drug Metab Dispos 2002, 30:1005-012. CrossRef
6. Liu T, Du F, Wan Y, Zhu F, Xing J: Rapid identification of phase I and II metabolites of artemisinin antimalarials using LTQ-Orbitrap hybrid mass spectrometer in combination with online hydrogen/deuterium exchange technique. / J Mass Spectrom 2011, 46:725-33. CrossRef
7. Xie LH, Li Q, Zhang J, Weina PJ: Pharmacokinetics, tissue distribution and mass balance of radiolabeled dihydroartemisinin in male rats. / Malar J 2009, 8:112. CrossRef
8. Ramu K, Baker JK: Synthesis, characterization, and antimalarial activity of the glucuronides of the hydroxylated metabolites of arteether. / J Med Chem 1995, 38:1911-921. CrossRef
9. Gordi T, Huong DX, Hai TN, Nieu NT, Ashton M: Artemisinin pharmacokinetics and efficacy in uncomplicated-malaria patients treated with two different dosage regimens. / Antimicrob Agents Chemother 2002, 46:1026-031. CrossRef
10. van Agtmael MA, Cheng-Qi S, Qing JX, Mull R, van Boxtel CJ: Multiple dose pharmacokinetics of artemether in Chinese patients with uncomplicated falciparum malaria. / Int J Antimicrob Agents 1999, 12:151-58. CrossRef
11. Elsherbiny DA, Asimus SA, Karlsson MO, Ashton M, Simonsson US: A model based assessment of the CYP2B6 and CYP2C19 inductive properties by artemisinin antimalarials: implications for combination regimens. / J Pharmacokinet Pharmacodyn 2008, 35:203-17. CrossRef
12. Svensson US, Ashton M: Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin. / Br J Clin Pharmacol 1999, 48:528-35. CrossRef
13. Khanh NX, de Vries PJ, Ha LD, van Boxtel CJ, Koopmans R, Kager PA: Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for Falciparum malaria. / Antimicrob Agents Chemother 1999, 43:690-92.
14. Diem Thuy LT, Ngoc Hung L, Danh PT, Na-Bangchang K: Absence of time-dependent artesunate pharmacokinetics in healthy subjects during 5-day oral administration. / Eur J Clin Pharmacol 2008, 64:993-98. CrossRef
15. Le Thi DT, Le NH, Nguyen CH, Phan Thi D, Na-Bangchang K: Pharmacokinetics of a five-day oral dihydroartemisinin monotherapy regimen in patients with uncomplicated falciparum malaria. / Drug Metab Pharmacokinet 2008, 23:158-64. CrossRef
16. Ueno K, Sato H, Ueno K, Sato H: Sex-related differences in pharmacokinetics and pharmacodynamics of anti-hypertensive drugs. / Hypertens Res 2012, 35:245-50. CrossRef
17. Simpson JA, Agbenyega T, Barnes KI, Di Perri G, Folb P, Gomes M, Krishna S, Krudsood S, Looareesuwan S, Mansor S, McIlleron H, Miller R, Molyneux M, Mwenechanya J, Navaratnam V, Nosten F, Olliaro P, Pang L, Ribeiro I, Tembo M, van Vugt M, Ward S, Weerasuriya K, Win K, White NJ: Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients. / PLoS Med 2006, 3:2113-123. CrossRef
18. Hong X, Liu CH, Huang XT, Huang TL, Ye SM, Ou WP, Wang NS, Mi SQ: Pharmacokinetics of dihydroartemisinin in Artekin tablets for single and repeated dosing in Chinese healthy volunteers. Pharmacokinetics of dihydroartemisinin in Artekin tablets for single and repeated dosing in Chinese healthy volunteers. / Biopharm Drug Dispos 2008, 29:237-44. CrossRef
19. Duthaler U, Keiser J, Huwyler J: Development and validation of a liquid chromatography and ion spray tandem mass spectrometry method for the quantification of artesunate, artemether and their major metabolites dihydroartemisinin and dihydroartemisinin-glucuronide in sheep plasma. / J Mass Spectrom 2011, 46:172-81. CrossRef
20. Xing J, Du FY, Liu T, Zhu FP: Autoinduction of phase I and phase II metabolism of artemisinin in rats. / Xenobiotica 2012, 42:929-38. CrossRef
21. Asimus S, Elsherbiny D, Hai TN, Jansson B, Huong NV, Petzold MG, Simonsson US, Ashton M: Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects. / Fundam Clin Pharmacol 2007, 21:307-16. CrossRef
22. Xing J, Kirby BJ, Whittington D, Wan Y, Goodlett DR: Evaluation of CYPs inhibition and induction by artemisinin antimalarials in human liver microsomes and primary human hepatocytes. / Drug Metab Dispos 2012, 40:1757-764. CrossRef
23. Burk O, Arnold KA, Nussler AK, Schaeffeler E, Efimova E, Avery BA, Avery MA, Fromm MF, Eichelbaum M: Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. / Mol Pharmacol 2005, 67:1954-965. CrossRef
24. Martignoni M, Groothuis GM, de Kanter R: Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. / Expert Opin Drug Metab Toxicol 2006, 2:875-94. CrossRef
25. Court MH: Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system. / Drug Metab Rev 2010, 42:209-24. CrossRef
26. Xing J, Bai KH, Liu T, Wang RL, Zhang LF, Zhang SQ: The multiple-dosing pharmacokinetics of artemether, artesunate, and their metabolite dihydroartemisinin in rats. / Xenobiotica 2011, 41:252-58. CrossRef - 作者单位：Fanping Zhu (1)
Fuying Du (1)
Xinxiu Li (1)
Jie Xing (1)
1. School of Pharmaceutical Sciences, Shandong University, 44# West Wenhua Road, Jinan, 250012, People’s Republic of China
文摘
Background Artemisinin (QHS) and its derivatives dihydroartemisinin (DHA), artemether and artesunate have become the first-line anti-malarials in areas of multidrug resistance. Declining plasma concentrations during the repeated dosing have been reported for QHS, artemether and less convincingly for artesunate (ARS). However, there is limited information on whether the concentrations of their active metabolite DHA and its subsequent metabolites increased after multiple drug administrations. This study was designed to evaluate the potential auto-induction metabolism of DHA in animal species. The sex-specific effect on the pharmacokinetic profiles of DHA and its metabolites was studied. The pharmacokinetics of ARS, the prodrug of DHA, and its phase I/II metabolites were also investigated. Methods Two groups of rats received a single oral dose of DHA or ARS, and another two groups of rats were given oral doses of DHA or ARS once daily for five consecutive days. Plasma samples were analyzed for DHA, ARS and their phase I/II metabolites, using a validated liquid chromatography tandem mass spectrometric (LC-MS) method. Results DHA, monohydroxylated DHA (M1) and the glucuronide of DHA (DHA-G) were detected in rat plasma after oral administration of DHA or ARS. Neither DHA nor its metabolites (M1 and DHA-G) changed significantly (P-gt;-.05) in AUC 0-t after 5-day oral doses of DHA or ARS. Sex difference was observed for DHA and its metabolites (M1 and DHA-G), whereas its prodrug ARS did not show similar characteristics for the corresponding metabolites (DHA, M1 and DHA-G). Conclusions The results gave the direct evidence for the absence of auto-induction of phase I and phase II metabolism of DHA and ARS in rats. The sex effect existed for DHA but not for ARS, which could be caused by the sex-specific differences in absorption of DHA.